Developing A Multi-Disease Risk Prediction Model Using Machine Learning

2025

Закрытый доступ Метаданные (CSL-JSON)
DOI 10.1109/aist68591.2025.11441609
Достоверность данных 70 средняя
Как считается эта оценка

Складывается из проверяемых признаков самой записи: есть ли у статьи DOI, сколько независимых источников подтвердили её данные, заполнены ли обязательные поля и насколько свежо последнее подтверждение. Снижают оценку расхождения между источниками и отсутствие идентификатора. Значение от 80 означает, что запись опубликована без дополнительной проверки; от 60 до 79 — что она опубликована с пониженной достоверностью и ручная проверка желательна. Запись, выверенную редактором вручную, пересчёт не опускает ниже 90. Это оценка наших данных о статье, а не оценка самой статьи.

Аннотация

The ability to predict the risk of multiple diseases accurately is a crucial step toward improving early diagnosis and healthcare outcomes. With the potential to improve and automate the diagnostic procedure, machine learning methods have become more effective instruments for this aim in recent years. This study focuses on developing a machine learning model to predict the risk of different diseases by using Transfer Learning, where pre-trained models are used to enhance the prediction accuracy. A comparison was done of three models, namely, Transfer Learning (proposed model), VGG-16, and DenseNet-121, in the multi-disease risk prediction context. The proposed Transfer Learning model reached a maximum accuracy of 98.3%, which is higher than the VGG-16 at 94% and DenseNet-121 at 92% in key evaluation metrics, such as precision, recall, and F1-score. This demonstrated how Transfer Learning could produce more balanced and accurate predictions of a variety of diseases, including influenza, asthma, diabetes, heart attacks, and many others. The findings provide evidence that Transfer Learning can indeed be applied to real-world health care scenarios, and it thus offers a very promising tool in the early prediction of disease. Future work will include fine-tuning the model, dealing with class imbalances in health datasets, and ensemble learning to enhance the model even further. Ultimately, this may then allow for an efficient deployment of machine learning models in clinical settings to improve disease diagnosis and manage risks.